FDA panel to review Qnexa in February 2012

MOUNTAIN VIEW, Calif. — The Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee is set to review an investigational treatment for obesity.

Biopharmaceutical company Vivus said the panel will review its new drug application for Qnexa on Feb. 22, 2012.

Meanwhile, the FDA will complete its review of the NDA for Qnexa on April 17, 2012. The regulatory agency accepted the NDA in November after Vivus' resubmission of the NDA in October.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.


- 1:35 AM
drjone says

It is really anyones guess as to what will happen here. If this is not prescribed to any woman who could become pregnant, I don't see the problem.

- 6:02 AM
arnold steveni says

I guess that something great and beneficial is going to happen here in this panel.I would like to recommend this to my friends and also to peolpe who are facing the problem of obesity.

- 4:19 AM
Ned Phan says

The drug should completely and thoroughly be reviewed and checked before it is introduced in the market..Many people will be waiting for this drug to be launched in the market as so many are facing the problem of obesity.

- 2:01 AM
Donny Ringold says

I has been that Qnexa and the other drugs would provide effective weight-loss without the dangerous side effects such as Fen-phen, Meridia and Alli. But FDA recently warned consumers about Alli's link to severe liver damage. I mean that sounds pretty dangerous. So stay away.

- 10:47 PM
jack1000 says

I would love to see this work for obesity. I hope to see more research done on this and get approved. There is so many people dealing with this and need help.

- 7:45 AM
arnold steveni says

I think that nowadays lot of people are facing the problem of obesity and hence such type of FDA panels will really be helpful for them. Regards, Arnold Steveni

- 5:15 AM
jamesgladson says

This is indeed a great news. This committee has taken valuable steps in reviewing the treatment for obesity. Inorder to overcome this , a new drug is introduced. Basically obesity is a condition which occurs when excess body fat is accumulated in the body. Regards, James Gladson

Login or Register to post a comment.